Andrographolide and its potent derivative exhibit anticancer effects against imatinib-resistant chronic myeloid leukemia cells by downregulating the Bcr-Abl oncoprotein

Liao, Hsin-ChiaHsin-ChiaLiaoChou, Yi-JuYi-JuChouLin, Ching-ChengChing-ChengLinLiu, Sheng-HungSheng-HungLiuOswita, AudreyAudreyOswitaHuang, Yi-LongYi-LongHuangWang, Ying-LienYing-LienWangSyu, Jia-LingJia-LingSyuSun, Chung-MingChung-MingSunLeu, Chuen-MiinChuen-MiinLeuLin, Chao-HsiungChao-HsiungLinFu, Shu-LingShu-LingFuYI-JU CHOU2020-04-282020-04-2820190006-2952https://scholars.lib.ntu.edu.tw/handle/123456789/486466[SDGs]SDG3Andrographolide and its potent derivative exhibit anticancer effects against imatinib-resistant chronic myeloid leukemia cells by downregulating the Bcr-Abl oncoproteinjournal article10.1016/j.bcp.2019.02.028WOS:000466060000030